参考文献/References:
［1］Mastrolia SA, Mazor M, Loverro G, et al. Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes［J］. PeerJ, 2014, 2(6): e653.
［2］Sagesaka T, Funabashi H. Change of the initiation time of blood coagulation in pregnancy from 10-months to postpartum ［J］. Clin Hemorheol Microcirc, 2013, 53(3): 247-255.
［3］Ataullakhanov FI, Koltsova EM, Balandina AN, et al. Classic and global hemostasis testing in pregnancy and during pregnancy complications ［J］. Semin Thromb Hemost, 2016, 42(7): 696-716.
［4］Stanciakova L, Dobrotova M, Jedinakova Z, et al. Monitoring of hemostasis and management of anticoagulant thromboprophylaxis in pregnant women with increased risk of fetal loss ［J］. Semin Thromb Hemost, 2016, 42(6): 612-621.
［5］CHAGAN-YASUTAN Haorile, Lacuesta TL, Ndhlovu LC, et al. Elevated levels of full-length and thrombin-cleaved osteopontin during acute dengue virus infection are associated with coagulation abnormalities ［J］. Thromb Res, 2014, 134(2): 449-454.
［6］Ornaghi S, Mueller M, Barnea ER, et al. Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis ［J］. Birth Defects Res C Embryo Today, 2015, 105(3): 209-225.
［7］Kusanovic JP, Espinoza J, Romero R, et al. Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor ［J］. J Matern Fetal Neonatal Med, 2007, 20(6): 453-463.
［8］Lockwood CJ. Pregnancy-associated changes in the hemostatic system ［J］. Clin Obstet Gynecol, 2006, 49(4): 836-843.
［9］HAN Lei, LIU Xiaojie, LI Hongmei, et al. Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia ［J］. PLoS One, 2014, 9(12): e114488.
［10］Dusse LM, Carvalho Md, Cooper AJ, et al. Tissue factor and tissue factor pathway inhibitor: a potential role in pregnancy and obstetric vascular complications?［J］. Clin Chim Acta, 2006, 372(1/2): 43-46.
［11］Erez O, Romero R, Vaisbuch E, et al. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor ［J］. Journal of Maternal-Fetal & Neonatal Medicine, 2010, 23(1): 23-33.
［12］Camire RM. Rethinking events in the haemostatic process: role of factor V and TFPI ［J］. Haemophilia, 2016, 22(Suppl 5): 3-8.
［13］Erez O, Romero R, Hoppensteadt D, et al. Tissue factor and its natural inhibitor in pre-eclampsia and SGA ［J］. J Matern Fetal Neonatal Med, 2008, 21(12): 855-869.
［14］Wikkels AJ. The role of fibrinogen and haemostatic assessment in postpartum haemorrhage: preparations for a randomised controlled trial ［J］. Dan Med J, 2015, 62(4): B5055.
［15］Polettini J, Dutta EH, Behnia F, et al. Aging of intrauterine tissues in spontaneous preterm birth and preterm premature rupture of the membranes: A systematic review of the literature［J］. Placenta, 2015, 36(9): 969-973.
［16］Kebapcilar AG, Taner CE, Kebapcilar L, et al. High mean platelet volume, low-grade systemic coagulation, and fibrinolytic activation are associated with pre-term delivery and low APGAR score in intrahepatic cholestasis of pregnancy ［J］. J Matern Fetal Neonatal Med, 2010, 23(10): 1205-1210.
［17］Maroney SA, Mast AE. New insights into the biology of tissue factor pathway inhibitor ［J］. J Thromb Haemost, 2015, 13(Suppl 1): S200-S207.
［18］Erez O, Gotsch F, Mazaki-Tovi S, et al. Evidence of maternal platelet activation, excessive thrombin Generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death ［J］. J Matern Fetal Neonatal Med, 2009, 22(8): 672-687.
［19］XIONG Yu, ZHOU Qiongjie, JIANG Fanglin, et al. Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy ［J］. Thromb Res, 2010, 125(6): e317-e322.
［20］Ebina Y, Ieko M, Naito S, et al. Low levels of plasma protein S, protein C and coagulation factor XII during early pregnancy and adverse pregnancy outcome［J］. Thromb Haemost, 2015, 114(1): 65-69.
［21］Jyotsna PL, Sharma S, Trivedi SS. Coagulation inhibitors and activated protein C resistance in recurrent pregnancy losses in Indian women ［J］. Indian J Pathol Microbiol, 2012, 54(4): 752-755.
［22］SOURI Masayoshi, Sugiura-Ogasawara M, Saito S, et al. Increase in the plasma levels of protein Z-dependent protease inhibitor in normal pregnancies but not in non-pregnant patients with unexplained recurrent miscarriage［J］. Thromb Haemost, 2012, 107(3): 507-512.
［23］Alshaikh FS, Finan RR, Almawi AW, et al. Association of the R67X and W303X non-sense polymorphisms in the protein Z-dependent protease inhibitor gene with idiopathic recurrent miscarriage ［J］. Mol Hum Reprod, 2012, 18(3): 156-160.
［24］Bar J, Schreiber L, Ben-Haroush A, et al. The placental vascular component in early and late intrauterine fetal death ［J］. Thromb Res, 2012, 130(6): 901-905.
［25］Kovo M, Schreiber L, Bar J. Placental vascular pathology as a mechanism of disease in pregnancy complications［J］. Thromb Res, 2013, 131(1): S18-S21.
［26］MOGAMI Haruta, Keller PW, SHI Haolin, et al. Effect of thrombin on human amnion mesenchymal cells, mouse fetal membranes and preterm birth ［J］. J Biol Chem, 2014, 289(19): 13295-13307.
相似文献/References:
[1]宋改让,傅晓冬,刘华梅,等.IL-6、CRP在子痫前期中的意义[J].中国计划生育和妇产科,2009,(05):0.
SONG Gai-rang,FU Xiao-dong,LIU Hua-meiThe department of gynaecology and obstetrics,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(6):0.
[2]赵昆.D-二聚体测定在产科常见病理性高凝状态疾病的临床意义[J].中国计划生育和妇产科,2011,(04):0.
ZHAO Kun.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(6):0.
[3]岳军,谢兰,陈廉,等.妊娠合并心脏病伴肺动脉高压43例临床分析[J].中国计划生育和妇产科,2011,(04):0.
YUE Jun,XIE Lan,CHEN Lian,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(6):0.
[4]刘丽,胥光热.先天性心脏病术后对妊娠结局的影响[J].中国计划生育和妇产科,2011,(06):0.
LIU Li,XU Guang-re ..[J].Chinese Journal of Family Planning & Gynecotokology,2011,(6):0.
[5]张峰,丁金云.子痫前期患者血清瘦素、sFlt-1/PLGF、C-反应蛋白及IP-10关系的研究[J].中国计划生育和妇产科,2012,(06):0.
ZHANG Feng,DING Jin-yun.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(6):0.
[6]乔宠,杨小梅,林其德,等.子痫前期的流行病学研究进展[J].中国计划生育和妇产科,2013,(06):0.
QIAO Chong,YANG Xiao-mei,LIN Qi-de,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[7]龚云辉,周容.子痫前期的预测和预警[J].中国计划生育和妇产科,2013,(06):0.
GONG Yun-hui,ZHOU Rong,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[8]顾宁,胡娅莉.子痫前期的预测和预防引发的思考[J].中国计划生育和妇产科,2013,(06):0.
GU Ning,HU Ya-li,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[9]郭宏霞,杨孜.子痫前期发病时期对母儿影响[J].中国计划生育和妇产科,2013,(06):0.
GUO Hong-xia,YANG Zi,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[10]宋亦军,刘俊涛.炎症与子痫前期[J].中国计划生育和妇产科,2013,(06):0.
SONG Yi-jun,LIU Jun-tao,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(6):0.
[11]李延杰.早发型重度子痫前期妊娠116例结局分析[J].中国计划生育和妇产科,2010,(02):0.
LI Yan-jie.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(6):0.